Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI

NCT: NCT05589415 · ACTIVE_NOT_RECRUITING

NCT IDNCT05589415
StatusACTIVE_NOT_RECRUITING
Start Date2020-11-23
Completion2027-05-23
SponsorUniversity of Texas Rio Grande Valley (OTHER)
First posted
Last updated

Brief Summary

The proposed project seeks to maximize the functional recovery achieved during the rehabilitation of the paretic upper limbs in individuals with SCI. The investigation will work towards optimizing the use of transcranial direct current stimulation (tDCS), an adjunct known to improve the effectiveness of rehabilitation. In particular, the relationship between the specificity of current delivery and functional benefit will be explored, and findings may lead to a framework that can be translated to the clinic setting.

Frequently Asked Questions

What is Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI?

Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI is a clinical trial registered under NCT05589415. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05589415?

The current status of NCT05589415 (Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI) is: ACTIVE_NOT_RECRUITING.

When did Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI start?

Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI started on 2020-11-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.